跳至主要内容
临床试验/NCT02019121
NCT02019121已完成不适用

Dexmedetomidine and Renal Transplants

University of California, Davis1 个研究点 分布在 1 个国家目标入组 797 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
797
试验地点
1
主要终点
Cr/GFR improvement, postoperative mortality/morbidity (within 30 days) and overall complications

研究概览

简要总结

Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients greater than or equal to 18 years old that underwent renal transplant at UC Davis Medical Center -

排除标准

  • Patients that did not undergo renal transplants and patients less than 18 years old will be excluded from the study.

结局指标

主要结局

Cr/GFR improvement, postoperative mortality/morbidity (within 30 days) and overall complications

时间窗: 5 years

次要结局

  • Graft failure, length of hospital stay (LOS), length of ICU stay, re-admission rate, infections, pulmonary complications.(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验